Where is the live CopyMark page for USPTO serial 86153175?

The live record is at https://getcopymark.com/trademark/86153175. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns MEDICINES THAT MAKE A DIFFERENCE?

According to the public USPTO record for serial number 86153175, the listed owner(s) include: Theravance, Inc., Theravance, Inc., THERAVANCE BIOPHARMA R&D IP, LLC.

What is USPTO serial number 86153175?

Serial number 86153175 is the USPTO application identifier for the mark MEDICINES THAT MAKE A DIFFERENCE. It is used to track examination, publication, and registration of this trademark.

What is the current status of MEDICINES THAT MAKE A DIFFERENCE?

MEDICINES THAT MAKE A DIFFERENCE (86153175) currently shows USPTO status code 605 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover MEDICINES THAT MAKE A DIFFERENCE?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: MEDICINES THAT MAKE A DIFFERENCE Serial# 86153175 | status 605; last event MAB5 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDICINES THAT MAKE A DIFFERENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Theravance, Inc.
South San Francisco, CA
Other trademarks owned by Theravance, Inc.
Theravance, Inc.
South San Francisco, CA
Other trademarks owned by Theravance, Inc.
THERAVANCE BIOPHARMA R&D IP, LLC
SOUTH SAN FRANCISCO, CA
Other trademarks owned by THERAVANCE BIOPHARMA R&D IP, LLC

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Beth H. Alter

Beth H. Alter Seward & Kissel LLPOne Battery Park PlazaNew York, NY 10004UNITED STATES

Goods and services

Class	Description	Status	First use
005	pharmaceuticals for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system; pharmaceuticals for the treatment of cancer and pain; anti-infectives; bi-functional and multibinding compounds sold as a component of pharmaceutical preparations for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system and for the treatment of cancer and pain and for use as anti-infectives	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
May 22, 2015	MAB5	ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	—
May 22, 2015	ABN5	ABANDONMENT - AFTER PUBLICATION	—
May 21, 2015	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Dec 10, 2014	EXRA	NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED	—
Dec 8, 2014	EX1G	SOU EXTENSION 1 GRANTED	—
Dec 8, 2014	EXT1	SOU EXTENSION 1 FILED	—
Dec 8, 2014	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2014	ASGN	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	—
Jun 10, 2014	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 15, 2014	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2014	NPUB	NOTICE OF PUBLICATION	—
Mar 6, 2014	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Mar 3, 2014	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 3, 2014	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Feb 28, 2014	DOCK	ASSIGNED TO EXAMINER	—
Jan 13, 2014	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Dec 31, 2013	NWAP	NEW APPLICATION ENTERED	—

MEDICINES THAT MAKE A DIFFERENCE